News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Sanofi-Aventis (France) Seeks Acquisitions, Has $5.1 Billion in Cash
February 3, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Feb. 2 (Bloomberg) -- Sanofi-Aventis SA Chief Executive Officer Chris Viehbacher told employees France’s largest drugmaker has 4 billion euros ($5.1 billion) and is seeking acquisitions, a union representative said.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Sanofi (France)
MORE ON THIS TOPIC
Mergers & acquisitions
Amgen Makes Up To $840M Cancer Play With Dark Blue Takeover
January 7, 2026
·
1 min read
·
Tristan Manalac
Podcast
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus
January 7, 2026
·
2 min read
·
Heather McKenzie
Insights
Biotech Investors Bet on a 2026 Rebound as Deal Activity Accelerates
January 7, 2026
·
3 min read
·
Jennifer Smith-Parker
Obesity
Lilly Doubles Down With Nimbus, Paying $55M for Preclinical Obesity Drug
January 6, 2026
·
2 min read
·
Heather McKenzie